Strata Critical Medical, Inc. Class A Common Stock SRTA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $254.27M+44.2% | $222.83M+16.1% | $192.44M-5.2% | $179.2M-24.8% | $176.34M-23.8% | ||
| $199.13M+41.8% | $174.76M+14.3% | $151.02M-5.6% | $141.89M-24.2% | $140.41M-24.6% | ||
| $55.14M+53.5% | $48.07M+23.2% | $41.42M-3.7% | $37.31M-27.0% | $35.93M-20.3% | ||
| 21.7%+1.3pp | 21.6%+1.2pp | 21.5%+0.3pp | 20.8%-0.6pp | 20.4%+0.9pp | ||
| —— | —— | —— | —— | $50.47M— | ||
| $7.97M+490% | $6.9M+448% | $4.2M+52.8% | $2.81M-34.2% | $1.35M-76.6% | ||
| —— | —— | —— | —— | $51.82M— | ||
| —— | —— | —— | —— | $51.82M— | ||
| -$19.96M+35.3% | -$22.67M+35.3% | -$22.17M+65.8% | -$23.64M+63.7% | -$30.83M+52.7% | ||
| -7.8%+9.6pp | -10.2%+8.1pp | -11.5%+20.4pp | -13.2%+14.1pp | -17.5%+10.7pp | ||
| $3.39M-47.5% | $4.24M-41.2% | $5.19M-34.2% | $5.83M-29.5% | $6.46M-24.5% | ||
| $3.59M— | $2.29M— | —— | —— | —— | ||
| -$16.37M+36.9% | -$20.38M+28.9% | -$22.42M+60.1% | -$18.39M+63.3% | -$25.94M+49.6% | ||
| $21K-59.6% | $21K+166% | $21K+102% | $21K+102% | $52K+104% | ||
| —— | —— | $40.39M+178% | -$18.98M+61.4% | -$26.57M+47.0% | ||
| -$20,065,999.95— | -$20,066,000.00— | -$22,108,000.00— | -$18,078,000.00— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $0.49+170% | -$0.24+64.2% | -$0.34+50.7% | ||
| —— | —— | $0.49+170% | -$0.24+64.2% | -$0.34+50.7% | ||
| 336M+7.3% | 325.7M+5.4% | 321.1M+5.3% | 316.7M+2.9% | 313M+3.1% | ||
| 331.2M+5.8% | 325.7M+5.4% | 321.1M+5.3% | 316.7M+5.2% | 313M+5.5% | ||
| —— | —— | —— | —— | $0— | ||
| $3.39M-47.5% | $4.24M-41.2% | $5.19M-34.2% | $5.83M-29.5% | $6.46M-24.5% | ||
| -$0.19— | -$0.24— | -$0.28— | -$0.23— | —— | ||
| -$0.19— | -$0.24— | -$0.28— | -$0.23— | —— | ||
| —— | —— | —— | —— | $1.35M— | ||
| -$16.05M— | -$20.07M— | -$22.11M— | -$18.08M— | —— | ||
| $254.27M+44.2% | $222.83M+16.1% | $192.44M-5.2% | $179.2M-24.8% | $176.34M-23.8% | ||
| -$19.96M+35.3% | -$22.67M+35.3% | -$22.17M+65.8% | -$23.64M+63.7% | -$30.83M+52.7% | ||
| -$10.41M+58.0% | -$14.48M+50.2% | -$15.46M+73.6% | -$17.35M+70.2% | -$24.77M+57.4% | ||
| -$10.41M+58.0% | -$14.48M+50.2% | -$15.46M+73.6% | -$17.35M+70.2% | -$24.77M+57.4% | ||
| -4.1%+10.0pp | -6.5%+8.6pp | -8%+20.8pp | -9.7%+14.8pp | -14%+11.1pp | ||
| -$19.96M+35.3% | -$22.67M+35.3% | -$22.17M+65.8% | -$23.64M+63.7% | -$30.83M+52.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Strata Critical Medical, Inc. Class A Common Stock's revenue?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated $254.3M in revenue over the trailing twelve months, up 44.2% year over year.
- Is Strata Critical Medical, Inc. Class A Common Stock profitable?
- Strata Critical Medical, Inc. Class A Common Stock reported $52.3M in net income over the trailing twelve months, a 21.0% net margin.
- What are Strata Critical Medical, Inc. Class A Common Stock's profit margins?
- Gross margin is 21.7% and operating margin is -7.8%, with a 21.0% net margin.
- What is Strata Critical Medical, Inc. Class A Common Stock's earnings per share?
- Strata Critical Medical, Inc. Class A Common Stock's diluted EPS over the trailing twelve months is $0.64.
- Where does Strata Critical Medical, Inc. Class A Common Stock's income statement data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
